Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

We did not find any age-specific differences in retinol binding protein or vitamin D levels.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We measured antibody and memory T cell immune responses to cholera antigens, micronutrient markers in blood, and EE markers in blood and stool from 40 Bangladeshi children aged 3 to 14 years who received two doses of OCV given 14 days apart.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

Study design awaiting verification · PLoS Neglected Tropical Diseases · 2016

Original publication title

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

Muhammad Ikhtear Uddin; Shahidul Islam; Naoshin S. Nishat; Motaher Hossain; Tanzeem Ahmed Rafique; Rasheduzzaman Rashu; Mohammad Rubel Hoq; Yue Zhang; Amit Saha; Jason B. Harris; Stephen B. Calderwood; Taufiqur Rahman Bhuiyan; Edward T. Ryan; Daniel T. Leung; Firdausi Qadri

© 2016 Uddin et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Environmental enteropathy (EE) is a poorly understood condition that refers to chronic alterations in intestinal permeability, absorption, and inflammation, which mainly affects young children in resource-limited settings. Recently, EE has been linked to suboptimal oral vaccine responses in children, although immunological mechanisms are poorly defined. The objective of this study was to determine host factors associated with immune responses to an oral cholera vaccine (OCV). We measured antibody and memory T cell immune responses to cholera antigens, micronutrient markers in blood, and EE markers in blood and stool from 40 Bangladeshi children aged 3 to 14 years who received two doses of OCV given 14 days apart.

EE markers included stool myeloperoxidase (MPO) and alpha anti-trypsin (AAT), and plasma endotoxin core antibody (EndoCab), intestinal fatty acid binding protein (i-FABP), and soluble CD14 (sCD14). We used multiple linear regression analysis with LASSO regularization to identify host factors, including EE markers, micronutrient (nutritional) status, age, and HAZ score, predictive for each response of interest. We found stool MPO to be positively associated with IgG antibody responses to the B subunit of cholera toxin (P = 0.03) and IgA responses to LPS (P = 0.02); plasma sCD14 to be positively associated with LPS IgG responses (P = 0.07); plasma i-FABP to be positively associated with LPS IgG responses (P = 0.01) and with memory T cell responses specific to cholera toxin (P = 0.01); stool AAT to be negatively associated with IL-10 (regulatory) T cell responses specific to cholera toxin (P = 0.02), and plasma EndoCab to be negatively associated with cholera toxin-specific memory T cell responses (P = 0.02).

In summary, in a cohort of children 3 to 14 years old, we demonstrated that the majority of biomarkers of environmental enteropathy were positively associated with immune responses after vaccination with an OCV.

Author Summary

Cholera is a life-threatening diarrheal disease that affects millions of people worldwide. Currently available oral cholera vaccines are less effective in young children, and some have hypothesized that this is related to environmental enteropathy, a problem in the gut characterized by alterations in intestinal permeability, absorption, and inflammation, which mainly affects young children in resource-limited settings. We measured cholera-specific immune responses in 40 Bangladeshi children aged 3 to 14 who received an oral cholera vaccine. We then identified host factors, such as enteropathy biomarkers, sex, age, and micronutrient status, associated with each immune response.

Unexpectedly, we found enteropathy biomarkers to be positively associated with immune responses to vaccine, underlining the complexity of the interaction between enteropathy and oral vaccine immunogenicity.

Authors’ abstract

Environmental enteropathy (EE) is a poorly understood condition that refers to chronic alterations in intestinal permeability, absorption, and inflammation, which mainly affects young children in resource-limited settings. Recently, EE has been linked to suboptimal oral vaccine responses in children, although immunological mechanisms are poorly defined. The objective of this study was to determine host factors associated with immune responses to an oral cholera vaccine (OCV). We measured antibody and memory T cell immune responses to cholera antigens, micronutrient markers in blood, and EE markers in blood and stool from 40 Bangladeshi children aged 3 to 14 years who received two doses of OCV given 14 days apart.

EE markers included stool myeloperoxidase (MPO) and alpha anti-trypsin (AAT), and plasma endotoxin core antibody (EndoCab), intestinal fatty acid binding protein (i-FABP), and soluble CD14 (sCD14). We used multiple linear regression analysis with LASSO regularization to identify host factors, including EE markers, micronutrient (nutritional) status, age, and HAZ score, predictive for each response of interest. We found stool MPO to be positively associated with IgG antibody responses to the B subunit of cholera toxin (P = 0.03) and IgA responses to LPS (P = 0.02); plasma sCD14 to be positively associated with LPS IgG responses (P = 0.07); plasma i-FABP to be positively associated with LPS IgG responses (P = 0.01) and with memory T cell responses specific to cholera toxin (P = 0.01); stool AAT to be negatively associated with IL-10 (regulatory) T cell responses specific to cholera toxin (P = 0.02), and plasma EndoCab to be negatively associated with cholera toxin-specific memory T cell responses (P = 0.02).

In summary, in a cohort of children 3 to 14 years old, we demonstrated that the majority of biomarkers of environmental enteropathy were positively associated with immune responses after vaccination with an OCV.

Author Summary

Cholera is a life-threatening diarrheal disease that affects millions of people worldwide. Currently available oral cholera vaccines are less effective in young children, and some have hypothesized that this is related to environmental enteropathy, a problem in the gut characterized by alterations in intestinal permeability, absorption, and inflammation, which mainly affects young children in resource-limited settings. We measured cholera-specific immune responses in 40 Bangladeshi children aged 3 to 14 who received an oral cholera vaccine. We then identified host factors, such as enteropathy biomarkers, sex, age, and micronutrient status, associated with each immune response.

Unexpectedly, we found enteropathy biomarkers to be positively associated with immune responses to vaccine, underlining the complexity of the interaction between enteropathy and oral vaccine immunogenicity.

Publication and source details

Original title: Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

Muhammad Ikhtear Uddin; Shahidul Islam; Naoshin S. Nishat; Motaher Hossain; Tanzeem Ahmed Rafique; Rasheduzzaman Rashu; Mohammad Rubel Hoq; Yue Zhang; Amit Saha; Jason B. Harris; Stephen B. Calderwood; Taufiqur Rahman Bhuiyan; Edward T. Ryan; Daniel T. Leung; Firdausi Qadri

PLoS Neglected Tropical Diseases · 2016

The authors have declared that no competing interests exist.

  • Conceptualization: MIU TRB ETR DTL FQ.

  • Data curation: MIU SI NSN YZ DTL.

  • Formal analysis: MIU SI YZ DTL FQ.

  • Funding acquisition: MIU RR MRH JBH SBC TRB ETR DTL FQ.

  • Investigation: MIU SI NSN MH TAR RR MRH.

  • Methodology: MIU TRB ETR DTL FQ.

  • Project administration: MIU SI AS TRB ETR DTL FQ.

  • Resources: MIU SI NSN MH TAR RR MRH YZ AS JBH FQ.

  • Supervision: TRB ETR DTL FQ.

  • Validation: MIU SI TRB DTL FQ.

  • Visualization: MIU SI YZ DTL FQ.

  • Writing: original draft: MIU SI RR DTL FQ.

  • Writing: review & editing: SBC TRB ETR DTL FQ.

‡ These authors are joint senior authors on this work. These authors share first authorship on this work.

* E-mail: fqadri@icddrb.org
© 2016 Uddin et al2016Uddin et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.http://dx.doi.org/10.13039/100000002National Institutes of HealthR01 AI106878Ryan Edward T. http://dx.doi.org/10.13039/100000002National Institutes of HealthR03 AI063079http://dx.doi.org/10.13039/100000002National Institutes of HealthU01 AI058935Calderwood Stephen B. http://dx.doi.org/10.13039/100000002National Institutes of HealthU01 AI058935Ryan Edward T. http://dx.doi.org/10.13039/100000002National Institutes of HealthK08AI100923Leung Daniel T. http://dx.doi.org/10.13039/100000002National Institutes of HealthR01AI103055Harris Jason B. http://dx.doi.org/10.13039/100000061Fogarty International CenterTW005572Bhuiyan Taufiqur Rahman Swedish Sida, SwedenINT-ICDDR,B-HN-01-AVThrasher Research Fund Early Career AwardLeung Daniel T. This research was supported by the icddr,b and by grants from the National Institutes of Health, including the National Institute of Allergy and Infectious Diseases (R01 AI106878 [ETR], U01 AI058935 [SBC, ETR], R03 AI063079 [FQ]), K08AI100923 [DTL], R01AI103055 [JBH]) and the Fogarty International Center, Training Grant in Vaccine Development and Public Health (TW005572 [MIU, RR, MRH, TRB]), as well as by Swedish Sida grant INT-ICDDR,B-HN-01-AV (FQ), and a Thrasher Research Fund Early Career Award (DTL). icddr,b is thankful to the donors for their support to its research efforts. icddr,b is also grateful to the Government of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:55:06.880585+00:00

DOI: 10.1371/journal.pntd.0005039 · PMC5100882